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otherwise inaccessible regions. Neverthe-
less, local uptake at the target requires 
drugs diffusion across the endothelial 
barrier lining the blood vessel walls and 
through the surrounding tissue.[1,2]
The endothelial layer is a tissue formed 
by a tessellation of specialized cells tight-
ened together by a system of protein com-
plexes, called interendothelial junctions. 
Two different transport pathways are 
known, namely the transcellular pathway 
implying molecule transport through 
the cellular membrane and the paracel-
lular pathway where the passage occurs 
between adjacent cells.[3] The central bio-
logical structure in transmembrane trans-
port is the cellular membrane, consisting 
of a lipid bilayer, where the hydrophilic 
lipid heads are exposed to the aqueous 
environments of the cytoplasm from one 
side and the extracellular matrix on the 
other, with the hydrophobic hydrocarbon 
tails sandwiched in the intraleaflet space. 
Concerning the paracellular pathway, the crucial elements are 
protein complexes known as junctions, which tight together 
neighboring endothelial cells. The junctions allow or deny 
transit of molecules depending on size and charge through a 
tightly regulated process.[3] Among others, adherent junctions 
comprise vascular endothelial cadherin (VE-cadherin), a protein 
responsible for vessel permeability and endothelial integrity.[4–6] 
This particular junction protein is clustered at cell–cell contacts 
and anchors to the actin cytoskeleton to form a dynamic pro-
tein complex the configuration of which rapidly adapts to the 
functional state of the cell.[7,8] Thanks to the fast response of the 
junctions to external stimuli, drug delivery may be coordinated 
by a suitably tuned mechanical actions able to induce their 
dynamic opening and closure which gives rise to a reversible 
interruption of the endothelial layer continuity.[9,10]
A crucial issue in controlled drug delivery is the assess-
ment of the biological effects induced by the external stimuli 
aimed at facilitating drug passage, which is especially difficult 
to achieve in vivo. Microfluidic systems provide the opportunity 
to manipulate fluids at the micrometer scale and to perform 
analysis under precise and reproducible conditions,[11] allowing 
for well controlled experiments that can be exploited to improve 
drug delivery efficiency and understand the underlying trans-
port mechanisms.[12–14] These systems have been used in 
different fields of biology and medicine, including development 
Targeting pharmaceuticals through the endothelial barrier is crucial for drug 
delivery. In this context, cavitation-assisted permeation shows promise for 
effective and reversible opening of intercellular junctions. A vessel-on-a-chip  
is exploited to investigate and quantify the effect of ultrasound-excited 
microbubbles—stable cavitation—on endothelial integrity. In the vessel-on-a-
chip, the endothelial cells form a complete lumen under physiological shear 
stress, resulting in intercellular junctions that exhibit barrier functionality. 
Immunofluorescence microscopy is exploited to monitor vascular 
integrity following vascular endothelial cadherin staining. It is shown that 
microbubbles amplify the ultrasound effect, leading to the formation of 
interendothelial gaps that cause barrier permeabilization. The total gap area 
significantly increases with pressure amplitude compared to the control. Gap 
opening is fully reversible with gap area distribution returning to the control 
levels 45 min after insonication. The proposed integrated platform allows 
for precise and repeatable in vitro measurements of cavitation-enhanced 
endothelium permeability and shows potential for validating irradiation 
protocols for in vivo applications.
1. Introduction
In drug delivery, therapeutic agents are most often injected sys-
temically in the circulation which is a preferred route to reach 
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of drug carriers,[15–17] point-of-care diagnostics,[18] and organs-
on-a-chips.[19–21] Organs-on-a-chips can be designed to incor-
porate the appropriate biophysical stimuli and can accelerate 
pre-clinical drug screening. In this way cost/time for new drug 
development can in principle be saved, minimizing the risk for 
the patient[22] and partially avoiding ethical issues related to in 
vivo studies.[23]
In particular, an in vitro microvasculature, designed to 
mimic vascular geometry and to reproduce the appropriate 
range of hydrodynamic forces, e.g., shear stress, will provide 
a significant advancement in drug delivery studies. Artificial 
vascular systems have been used for studying different drug 
delivery protocols, including engineered drug carriers,[24–26] 
electroporation,[27] and acoustic mediated delivery and 
release.[2,28] Cavitation is an especially promising technique 
for facilitating drug delivery.[29,30] In this context, it can be 
defined as the dynamics of a population of microbubbles (MBs) 
stimulated into motion by ultrasound (US) which results in a 
localized mechanical action.[31] The bubbles may be naturally 
present/nucleated in the tissue or may be introduced by injec-
tion. In the latter case the preferential administration route is 
intravenous.
Experimental findings show that the application of high 
intensity US may result in transient cavitation, including 
bubble nucleation, expansion, collapse, and subsequent shock 
waves.[32] Theoretical models of lipid bilayers[33] focus the atten-
tion on the hydrophobic chains forming the inner layer between 
the two membrane leaflets which may host dissolved gas. 
Under the negative pressure due to US excitation, gas pockets 
may form in the intraleaflet space nucleating MBs. Their sub-
sequent expansion would lead to membrane permeabilization 
by mechanically forcing the bilayer structure and the junctions 
holding together the endothelium. The model may explain why 
relatively moderate US excitation is able to induce significant 
bioeffects. However, when pre-existing MBs are injected before 
sonication, the required acoustic power level is substantially 
reduced and the effect is restricted in more controllable way to 
the vasculature. In this way, adverse bioeffects, i.e., ischemic, 
apoptotic areas, or bleeding are mitigated.[34]
Externally injected MBs, typically lipid shells encapsu-
lating a heavy molecular weight inert gas,[35] were originally 
introduced and are still used clinically as contrast agent in 
US imaging.[36,37] More recently, they have been proposed for 
therapeutic applications, drug delivery in particular.[38,39] In[40,41] 
it was shown that the combination of US exposure and MBs 
is able to transiently and reversibly permeabilize the endothe-
lium. Once introduced into the bloodstream and irradiated with 
ultrasound, MBs may oscillate (stable cavitation) or collapse 
(inertial cavitation). Different mechanisms may be at work to 
explain why MBs alter the integrity of the endothelium. In the 
classical view, stable MBs oscillations induce a microstreaming 
and related shear stress at the vessel wall that are transmitted 
to the junctions, while inertial cavitation leads to more intense 
forcing through shock wave emitted at bubble collapse and 
associated microjetting.[30,42] Alternatively, in the scheme intro-
duced in,[33] MBs may just act as sort of local acoustic amplifiers 
that favor nucleation of intraleaflet nanobubbles which, in turn, 
deform the membrane and force the junctions. In any case, the 
observed result is a sequence of biological effects comprising 
formation of pores into the cellular membrane and increase of 
intercellular distance. Bioeffects of USMB on cells and tissues 
are strictly related to the level of the applied acoustic pressure. 
At sufficiently intense irradiation level, in conditions of inertial 
cavitation, biological damage may follow, e.g., tissue disruption, 
bleeding, apoptosis, and necrosis.
As anticipated, adherent junctions comprise vascular 
endothelial cadherin, that exhibits a wide heterogeneity of 
morphologies ranging from interrupted patterns to linear, 
reticular, or plaque-like structures. These patterns are continu-
ously reorganized by actin filament remodeling that promotes 
VE-cadherin clusterization at junction sites.[43] The shear 
stress exerted by the blood flow on the endothelial cells in the 
microvasculature (typically 1–12 dyn cm−2 under physiological 
conditions[44–46]) is crucial to achieve an endothelial phenotype 
characterized by streamwise cell elongation and actin-mediated 
stabilization of junction proteins. Under low flow rate, 
VE-cadherin forms an irregular overlapping network. At high 
flow rate, actin drives VE-cadherin remodeling into an overall 
linear pattern strengthening the barrier function.[6,47]
Formation of stable junctions is not sufficient for a functional 
endothelium. In fact, a proper shear stress is also needed for 
cell adhesion to the substrate.[48] In artificial, microfabricated 
blood vessels, wall functionalization by the extracellular matrix 
protein fibronectin is crucial to bind the endothelial cell basal 
layer to the underlying substrate via focal adhesions, namely the 
subcellular structures devoted to anchor the endothelial cells.[49] 
In presence of fibronectin coating, a sufficiently intense shear 
stress is also known to promote focal adhesions, leading to an 
overall confluent and well attached endothelium.[50]
US irradiation of MBs shows great potential for endothelium 
permeabilization, hence the growing interest for basic studies 
aimed at quantifying the effect of the irradiation on endothelial 
barrier function. The application of USMB in mimetic in vitro 
systems is therefore a valuable alternative to in vivo animal 
models. Current in vitro models of the endothelial barrier 
comprise permeable membranes covered with an endothelial 
monolayer immersed in liquid tanks where MBs are injected 
and irradiated by US.[51,52] Alternatively, tissue phantom models 
consisting of an agarose-gel tissue platform optimized to hold 
the bubble suspension are used to study tissue-like response 
to USMB irradiation.[53] While these devices have significantly 
contributed to our understanding of cavitation in tissues, they 
are limited by the lack of physiological flow conditions and 
appropriate vessel geometry which, as explained above, are 
crucial to achieve a functional endothelial barrier.
Recently, a relatively simple and effective microfluidic 
network has been proposed[54] which mimics the in vivo vas-
cular system allowing for complete lumen formation under 
physiological flow conditions. This system has been used 
to mimic the blood–brain barrier (BBB) and characterize its 
permeability[54] or study the signaling pathway in neuroin-
flammation during sepsis.[55] In the present paper, we use this 
system to characterize cavitation-enhanced endothelium per-
meability. Human umbilical vein endothelial cells (HUVECs) 
are cultured to form complete lumens lining two independent 
microchannels encircling an inner tissue chamber, see 
the Experimental Section below. Microchannels and tissue 
chamber are connected through a membrane endowed with 
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micrometer size pores. MBs are injected into the channels and 
are irradiated by low intensity US (0.4 and 0.72 MPa) at 1 MHz 
to force stable acoustic cavitation. In the same conditions 
(SonoVue microbubbles, irradiated at 1 MHz, with pulse length 
(PL) = 500 µs, pulse repetition frequency (PRF) = 20 Hz, total 
pulse number 600, fluid speed of 0.83 mm s−1) the threshold 
for inertial cavitation is 0.86 MPa. In fact, the inertial cavita-
tion threshold depends on a number of factors,[56] e.g., pressure 
amplitude, excitation frequency, PL, and PRF. The bubble con-
vection speed also matters, since in an intermediate excitation 
range the inertial response is transient and strongly depleted 
after the first pulse. As a consequence, the threshold for fully 
inertial cavitation increases at decreasing convection speed. In 
the present case, the low fluid speed of 0.83 mm s−1 raises the 
threshold at 0.86 MPa,[56] as anticipated.
The effect on the endothelium is identified by immunofluo-
rescence staining of junctions and actin filaments to detect the 
induced morphological changes. The efficacy of US, with and 
without MBs, is monitored and quantified in a highly reproduc-
ible fashion at different stages of the irradiation process. The 
endothelial layer integrity recovery under different irradiation 
protocols is finally assessed.
2. Results
2.1. Vessel-on-a-Chip Characterization
The vascular channel in our system is illustrated in Figure 1A 
showing a composite brightfield picture of the endothelium 
reconstructed from several high resolution images 
(20× magnification, 1940 × 1460 px). A uniform endothelial layer 
forms a complete lumen in the channel with individual cells 
elongated in the direction of flow from left to right. Confocal 
fluorescence images of cell nuclei stained with 4′,6-diamidino-
2-phenylindole (DAPI) show that the cells completely line the 
vessel walls, Figure 1B–D corresponding to three planes at the 
bottom, middle (note that cells are in this case present only on 
the side walls) and top of the channel, respectively. Staining with 
Calcein, a cell-permeant dye, confirms cell viability (data not 
shown). This analysis validates that a uniform, 3D endothelial 
barrier is formed throughout the channel section, reproducing 
and resembling the structure of a physiological capillary vessel.
2.2. Endothelium Maturation
The maturation of a confluent HUVEC layer, namely the cob-
blestone phenotype with established barrier function,[57] is 
confirmed by immunofluorescence microscopy at different cul-
ture stages and flow rates. A complete HUVEC layer is obtained 
after a 3-day on-chip culture and is characterized using immu-
nolabeling visualization of VE-cadherin protein and of actin 
filaments. A crucial feature for endothelial cell shape main-
tenance, movement, and vascular integrity is the effective 
anchorage of VE-cadherin to the cytoskeleton.[5] Endothelial 
cells sense the applied shear force and respond by remodeling 
the cytoskeleton[8] which, in turn, alters the tension forces on 
the junction proteins in a time-dependent manner.
Small 2019, 1905375
Figure 1. Vessel-on-a-chip. A) Brightfield image of HUVECs seeded in the vascular channel. The inset highlights the elongation of cells in the direction 
of flow. B–D) Fluorescence images of cell nuclei shown after DAPI staining. Top (panel B), middle (panel C), and bottom (panel D) sections of the 
vascular channel. In panel (B) and (D), the nuclei of the cells in the top and bottom channel wall are visible. The nuclei focused in panel (C) belongs 
to cells adhered on the lateral walls of the channel.
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During the 3-day culture, cells were first exposed to a 
24-hour ramp up flow followed by a 2-day exposure to a con-
tinuous low (0.5 µL min−1) or high (25 µL min−1) flow rate. 
In order to obtain a compact endothelium the initial cell den-
sity is crucial (60–70% confluence optimized for HUVECs). 
During maturation, the endothelium structure develops from 
an initial disorganized configuration to compact endothelial 
layers (90–95% confluence); see Figure 2A,B, obtained under 
25 and 0.5 µL min−1 flow, respectively corresponding to 10 and 
0.2 dyn cm−2.
During the initial phase cells grow and tend to connect to 
each other through the plasma membrane. The process is par-
ticularly evident in subconfluent conditions, see Section SM1 
in the Supporting Information. The process requires actin 
filament remodeling as highlighted by the numerous stress 
fibers traversing the cytoplasm (center panel in Figure SM1 
in the Supporting Information). In these conditions, cells are 
apparently larger and their perimeter is longer than under con-
fluent conditions (left panel of Figure SM1 in the Supporting 
Information). The VE-cadherin pattern is discontinuous and 
formed by multiple short linear elements connected to stress 
fibers and projecting normally from the cell border toward the 
neighboring one (right panel of Figure SM1 in the Supporting 
Information). Once cell contact is achieved, the actin-driven 
VE-cadherin clusterization takes place, providing a well estab-
lished, resting confluent state (Figure 2A) when cells acquire 
a polygonal shape while reducing the junction perimeter. At 
this stage, VE-cadherin is well localized at the cell periphery, as 
expected of a tight cobblestone monolayer.[57] The VE-cadherin 
pattern becomes linear and well packed, with evident reticular 
networks (see the arrow in the right panel in Figure 2A). Along 
the process, actin reorganizes into cortical filaments aligned 
with the junctions with no stress fiber inside the plasma mem-
brane (center panel in Figure 2A). Under this condition, vas-
cular stability—, e.g., contact inhibition of growth, endothelial 
integrity and reduced loss of cells—was observed as discussed 
in.[58]
A similar mature endothelial layer was also obtained at 
low flow rate (0.5 µL min−1, corresponding to a 0.2 dyn cm−2 
shear stress). In this almost static condition, partial vessel wall 
detachment from the microfluidic channel is often observed 
(see the left panel of Figure 2B where the endothelium miss to 
perfectly follow the microchannel profile), presumably due to 
lack of focal adhesion expression.
2.3. Bubbles Injection and US Exposure
After endothelium maturation, the microfluidic chip is trans-
ferred to the insonication chamber described in the Experi-
mental Section which is placed on the microscope stage. 
MBs (Sonovue) are then injected in the vascular channels 
and activated by US. The insonication protocol consists of a 
sequence of bursts at 1 MHz formed by 500 cycles repeated 
every 50 ms for a total duration of 30 s with 0.1% duty cycle 
(DC). As the bubble residence time over a region of the 
endothelium matters when it comes to the bioeffects induced 
under insonication, the perfusion rate is transiently reduced 
to 1 µL min−1 upon US exposure. Slowing down the flow 
results in a more faithful reproduction of the bubbles dynamics 
in capillaries, where the convective velocity is in the range 
0.5–1.5 mm s−1.[59] Under such mild flow the acoustic forces 
acting on the bubbles are sufficient to temporarily keep the bub-
bles at rest with respect to the endothelium. MBs distribute 
homogeneously along the channel and tend to approach the 
upper endothelial wall, due to buoyancy, Figure 3A. Time-lapse 
imaging reveals that US radiation forces slow down the MBs 
initially and eventually lead to their agglomeration, resulting 
in evenly spaced bubble clusters[60] (see yellow circles in 
Figure 3B and the video SM2 in the Supporting Information). 
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Figure 2. Endothelium maturation. Confocal fluorescence images of the endothelium at 90–95% confluence at different flow rate. A) Physiological flow 
rate (25 µL min−1). B) Flow rate: 0.5 µL min−1. Left column: overlay of fluorescence images showing cell nuclei (blue, DAPI), actin filaments (green, 
PhalloidinAtto488), cell junctions (red, VE-cadherin). Middle column: inset showing stress fibers (actin filaments). Right column: inset showing cell 
junctions (VE-cadherin).
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The effect of the convection velocity has been explored in dedi-
cated experiments where the flow rate was changed in the 
range 1–25 µL min−1. The data shown in Figure SM3 in the 
Supporting Information confirm that the desired bioeffect is 
obtained at the smaller flow rates while at 25 µL min−1 the MB 
residence time is apparently insufficient.
2.4. Bioeffects and Data Analysis
Modification of the intercellular junctions induced by US 
(at 0.4 and 0.72 MPa radiation pressure), with and without MBs, 
is evaluated by image analysis of VE-cadherin. The image anal-
ysis, the Experimental Section, consists of identifying the gaps 
present in the endothelial layer, quantifying their area in terms 
of pixels (1 pixel = 0.22 × 0.22 µm2 in our imaging system) 
and number. Figure 4A shows the image of a vascular channel 
used as control with the main features already discussed in 
Section 2.2. Intercellular gaps for samples irradiated with US at 
0.72 MPa pressure with no MBs and with MBs, respectively, are 
shown in Figure 4B,C. VE-cadherin was stained within 4 min 
after the end of irradiation to allow time to extract the sample 
from the insonication chamber and inject paraformaldehyde 
(PFA) (see the Experimental Section) into the vascular channels 
under the biological hood.
The acoustic radiation forces, either acting directly on 
the cells, Figure 4B, or combined with the oscillating MBs, 
Figure 4C, induce local disruptions of cell–cell contacts (exam-
ples highlighted by arrows) that are identified by VE-cadherin 
reorganization. The number of intercellular gaps and their 
areas, obtained by image postprocessing (see the Experimental 
Section), are plotted in Figure 5A,B for vascular channels irradi-
ated at 0.4 and 0.72 MPa, respectively. The histograms show the 
area distributions for control, US and USMB samples, each of 
them obtained after averaging over three experiments. From the 
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Figure 3. Brightfield images showing a portion of the vascular channel 
with injected microbubbles. A) MBs transported by the flow before 
irradiation. B) MB cluster formed under US-induced radiation forces. The 
yellow circles highlight a single bubble (A) and a cluster (B), respectively.
Figure 4. Confocal fluorescence images of VE-cadherin showing a region 
of confluent endothelium cultured at 25 µL min−1. A) Untreated sample 
(CTRL). B) Ultrasound irradiated sample (US). C) Bubble injected 
ultrasound irradiated sample (USMB). Acoustic pressure 0.72 MPa 
corresponding to piezo driving voltage of 140 mV. Irradiation protocol: 
duration 30 s, 500 cycles, frequency 1 MHz. Arrows highlight typical 
intercellular openings.
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Figure 5. Junction opening. Number of gaps versus gap area. Comparison between untreated samples (CTRL), ultrasound irradiated samples (US), and 
bubble injected ultrasound irradiated samples (USMB). Area expressed in pixel where 1 pixel = 0.225 × 0.225 µm2. A) Irradiation pressure: 0.4 MPa. 
B) Irradiation pressure: 0.72 MPa. Same irradiation protocol as in Figure 3. The insets report for each case the total gap area over the entire vascular 
channel. Asterisks are reported for cases with statistical significance: ** CTRL versus US: p = 0.0053, *** CTRL versus USMB: p = 0.0004, and US 
versus USMB: p = 0.0007.
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histograms, the main effect of US and USMB is the increase of 
the number of gaps, as shown by the shape of the distribution 
which, to a first approximation, is almost unaltered with respect 
to the control. The total gap area is illustrated in the insets. 
These findings indicate that US alone at the lower acoustic 
pressure, 0.4 MPa, has no substantial effect on the endothe-
lium integrity. Acoustic pressure increase of 0.72 MPa leads to 
a significant total gap area increase. The overall effect ampli-
fies dramatically in presence of MBs, with the total gap area 
growing mildly over the US alone case at 0.4 MPa, to become 
130% at 0.72 MPa. The increase of USMB total gap area is 
significant as compared with the control case, for 0.72 MPa, i.e., 
360%. Although much smaller, it is also observed at 0.4 MPa, 
see the error bars reported in the inset.
Endothelium integrity recovery 45 min after the end of the 
irradiation protocol is evaluated by staining the irradiated sam-
ples exposed to the physiological shear stress of 10 dyn cm−2. 
As shown in Figure 6A,B for 0.4 and 0.72 MPa irradiation pres-
sure, respectively, endothelium integrity is completely recov-
ered, with gap area distributions returning to control values, 
and with no significant difference between US and USMB 
values for both pressures, indicating that the opened inter-
cellular spaces do close back after irradiation. The total gap 
area measured after 45 min reproduces that of the untreated 
vascular channels (insets on the left of Figure 6A,B). The two 
insets on the right of Figure 6A,B provide the comparison of 
gap area distributions for USMB just after irradiation and after 
45 min recovery. Apparently, during recovery the large number 
of relatively small gaps formed by cavitation close entirely. Data 
collected after 15 min from US exposure indicates that the 
closure of gaps is not concluded yet, suggesting that the 
recovery is still in progress and entirely complete within 
45 min, see Figure SM4 in the Supporting Information.
Figure 7 shows the same data of Figures 5 and 6 rear-
ranged to allow for direct appreciation of the pressure ampli-
tude effect. Figure 7A shows gap areas for the two USMB cases 
(0.4 and 0.72 MPa) immediately after irradiation compared to 
the control.
With increasing irradiation pressure, the shape of the distri-
bution is substantially unaltered, apart from a slight shift of the 
distribution towards larger gaps, with the probability density 
function (pdf) at both 0.72 and 0.4 MPa reproducing the shape 
of the control (lower inset of Figure 7A,B). As already discussed 
in Figure 5, the total gap area is greatly increased over the con-
trol for the irradiation of 0.72 MPa. The difference is smaller, 
though appreciable with the available statistical accuracy, for 
0.4 MPa.
As shown in Figure 7B, 45 min after irradiation, total gap 
area returns to control for both pressure amplitudes. Within 
statistical accuracy, the gap area histograms reproduce the 
control, demonstrating the endothelium integrity recovery for 
both cases.
As discussed in Section 2.2, endothelium maturation under 
appropriate shear stress (physiological 1–12 dyn cm−2[37–39]) is 
crucial to achieve a physiological barrier. Figure 8A highlights 
the effect of cavitation on an unstable endothelium cultured 
at a flow rate of 0.5 µL min−1 (shear stress of 0.2 dyn cm−2). 
The figure shows the gap area distribution for the control case, 
under simple US irradiation and when irradiation is applied 
in presence of MBs. The comparison of the untreated sam-
ples with those cultured at physiological shear stress indicates 
that the endothelium morphology is substantially the same 
(leftmost inset). Also the gap area distribution for the irradi-
ated endothelium with no MBs is substantially similar to that 
found at physiological shear stress (middle inset) with gap 
number and total gap area slightly larger. The rightmost inset, 
however, demonstrates that irradiated MBs produce a substan-
tially larger effect on the endothelium cultured under almost 
static conditions with considerable increase of the gap number 
with respect to endothelium cultured under physiologically rel-
evant flow conditions. Figure 8B shows the fluorescence image 
of gaps formed in the endothelium cultured at 0.5 µL min−1 
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Figure 6. Junction recovery. Number of gaps versus gap area 45 min after US irradiation. Comparison between untreated samples (CTRL), ultrasound 
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after MBs irradiation. These findings indicate that the unstable 
endothelium obtained with low flow rate culture condition is 
more prone to gap formation, particularly in presence of MBs. 
In other words, the sensitivity of the endothelium to US irra-
diation and MB cavitation is significantly dependent on the 
culture conditions. This observation is consistent with our find-
ings presented in Section 2.2, where the appropriate flow rate is 
found crucial also for the proper adhesion of endothelial cells 
to the substrate.
3. Conclusions
A vessel-on-a-chip reproducing the physiological features of 
actual microvasculature is exploited to quantify the effect of 
stable cavitation on the reversible opening of intercellular 
junctions. The flow-induced shear stress on the endothelium 
cultured inside the microfluidic device is found to crucially 
affect the intercellular junction strength, with the physiological 
level of shear stress determining the morphology of adherent 
junctions and actin cytoskeleton. VE-cadherin staining was 
used to investigate the response of the junctions to US and 
to MB cavitation. Although US alone is able to open gaps in 
the mature endothelium, the presence of MBs excited by US 
at resonance conditions largely increases gap number, with the 
total gap area increasing by 360% of that found in the intact 
endothelium. Interestingly, the gap area distribution seems to 
be quite insensitive to the magnitude of irradiation. The forma-
tion of gaps under US irradiation depends on the culture condi-
tions, with gap number and total area increasing for endothelia 
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cultured at shear stress lower than the physiological value. 
Endothelium cultured under insufficient shear stress intensity 
is prone to instability and tends to detach from the substrate 
entailing vessel collapse, presumably induced by lack of focal 
adhesions. A central finding is that the effect of stable MBs 
cavitation is transient and reversible since in all the cases we 
investigated the endothelial barrier reverts to the original state 
after removing US irradiation.
The proposed platform combining the vessel-on-a-chip with 
controlled MBs injection and US irradiation provides a new 
and original methodology for the quantitive understanding of 
cavitation-assisted drug delivery. The present results demon-
strate how permeabilization can be achieved in controlled and 
reproducible conditions paving the way to new detailed studies 
on the physical and biological mechanisms underlaying junc-
tion opening. The use of pre-existing bubbles (MB-assisted, 
cavitation-enhanced endothelium permeability) reduces the 
intensity of US irradiation thereby mitigating potential adverse 
bioeffects, e.g., bleeding, apoptosis, and necrosis.
From the clinical point of view, potential hazard posed by US 
irradiation is a crucial aspect. Although clinical protocols are 
not yet available, a rich literature describes promising results 
in this direction using in vivo models[1,61] [6,10-risposta]. In 
this context, an in vitro platform able to reproduce many of the 
aspects found in in vivo applications under strictly controlled 
and reproducible conditions may contribute a significant 
advancement of the state of the art in the field. The typical US 
frequency used in in vivo studies ranges from 0.3–3 MHz, the 
Peak Negative Pressure may vary from 0.24 to 5.3 MPa corre-
sponding to a Mechanical Index of 0.2–1.9, the latter being the 
upper limit indicated in FDA recommendations as potentially 
hazardous [link]. The pulse length is typically in the order of 
ms and the US intensities used for delivery applications range 
between 0.3–3 W cm−2. Higher intensity US can be applied 
when the pulse length and/or pulse repetition frequency are 
reduced, resulting in low duty cycles. In the present case, with 
PL = 500 µs and DC = 0.1%, i.e., a decreased temporal average 
intensity, the irradiation intensity of 5 and 17 W cm−2 matches 
the insonication parameters indicated in in vivo protocols.
In perspective, artificial platform like the present, may even-
tually help in streamlining the search for safe administration 
protocols in clinical application. The proposed approach could 
be used for preliminary assessment of potential hazards and 
the prevention of permanent damage to the blood vessel, not-
withstanding the need of direct experimentation in vivo and the 
necessity of preclinical trials that remain, as yet, the conclusive 
safety certification. To this purpose, a dedicated experimental 
set up was developed to evaluate the artificial endothelial 
barrier tightness in different conditions (i.e., control, US 
excitation, USMB irradiation). The endothelial membrane 
permeability is quantified by measuring the diffusion of a fluo-
rescent dye through the biological membrane with a time lapse 
acquisition under the confocal microscope, see the preliminary 
result described in Figure SM5 in the Supporting Information. 
The figure shows the time evolution over 2 h of fluorescence 
intensity diffused in the tissue compartment from the vascular 
channel across the endothelium with and without USMB appli-
cation. In brief, as expected, USMB application induces an 
enhanced barrier permeability while US alone follows a time 
history comparable to the control, suggesting that the acoustic 
irradiation does not damage the tissue. This approach may 
contribute to address potential hazard posed by US with more 
detailed permeability studies.
The present system, originally conceived to demonstrate the 
feasibility of an in vitro blood-vessel on a chip for the quantita-
tive study of cavitation-enhanced endothelium permeabilization, 
is also open to further developments in different directions. 
The microdevice could be embedded within phantom tissues 
to reproduce the irradiation conditions of in vivo applications 
where high intensity focused ultrasound (HIFU) devices are 
used to reach inaccessible and restricted target regions deep 
inside the body. The microsystem could allow for addressing 
complete drug delivery protocols explicitly including different 
types of drug carriers and the interaction with a variety of 
tissues that can be cocultured in the central tissue chamber.
4. Experimental Section
Vessel-on-a-Chip: The vessel-on-a-chip developed in this study is 
based on a microfluidic device distributed by SynVivo, Inc (Huntsville, 
AL). The device consists of a polydimethylsiloxane (PDMS) chip 
(Figure 9A,B) plasma bonded to a microscope glass slide with a central 
tissue compartment (1575 µm width, 100 µm height) encircled by 
two independent vascular channels (200 µm width, 100 µm height). 
An interface with a series of 3 × 3 µm2, 50 µm-spaced pores along 
the circumference separates the vascular channels from the tissue 
compartment. The vascular channels were seeded with endothelial cells 
which, after adhesion to the substrate, mimic the 3D morphology of an 
in vivo microvessel.
Cell Culture: HUVECs were purchased from Lonza (Walkersville, MD, 
USA). The culture medium was the endothelial basal medium-2 (EBM-2) 
supplemented with the endothelial growth medium (EGM-2) BulletKit 
from Lonza (Walkersville, MD, USA). Cells were grown in tissue culture 
flasks and maintained in humidified atmosphere at 37 °C and 5% CO2. 
The culture medium was changed every 2 days and cells were used up 
to the 5th passage to ensure the expression of key endothelial protein 
components.
Cell Seeding: The protocol was used to seed the HUVECs into the 
microfluidic device.[54,62] Culture flasks with 80–90% HUVEC confluence 
were washed twice with Dulbecco Phosphate Buffered Saline (PBS) 
(Sigma Aldrich, Missouri, USA), detached using Trypsin-EDTA solution 
(Sigma-Aldrich, Missouri,USA) for 40 s at 37 °C in 5% CO2 and 
blocked with Trypsin inhibitor (Sigma-Aldrich, Missouri, USA). The cell 
suspension was collected and centrifuged at 1400 rpm for 7 min at 
room temperature (RT) and the supernatant was discarded. Cells were 
resuspended in filtered culture medium at an average concentration 
of 108 cells mL−1. To form an endothelial monolayer into the PDMS 
channels, the device was first degassed, washed with PBS and then 
coated with 200 µg mL−1 fibronectin (Sigma-Aldrich, Missouri,USA) at 
37 °C and 5% CO2. After 2 h, the HUVEC suspension was injected into 
the vascular channels, using a syringe programmable pump (PhD ULTRA 
Syringe Pump, Harvard Apparatus, Massachusetts, USA). The input 
and output tubings were clamped when HUVECs reached the desired 
confluence (60–70%) and the device was placed in the incubator for 4 h, 
to let the cells attach to the channels inner walls in static condition. After 
incubation, the vascular channels were connected to a double syringe 
pump and growth medium was pulled into the channel using Tygon 
tubings (Saint Gobain PPL Corp., Pennsylvania, USA). To orient the cells 
in the flow direction, perfusion rate was ramped up to 0.5 µL min−1 over 
24 h. Culture medium was then refreshed and injected into the channel 
at the desired flow rate (0.5 and 25 µL min−1, corresponding to a shear 
stress of 0.2 and 10 dyn cm−2, respectively). These flow conditions were 
kept for additional 2 days to achieve full junction maturation.
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Immunofluorescence Staining: The state of the endothelial junctions 
at different stages of the experiment (i.e., maturation, ultrasound 
excitation, MB irradiation and eventual recovery) was assessed 
by fluorescence imaging following VE-cadherin protein, a crucial 
component of inter endothelial junctions. In addition, actin filaments 
rearrangement was also monitored. For staining, incubations and 
washings into the microchannels were performed at 0.5 µL min−1 flow 
rate unless otherwise stated. Cells were first washed for 30 min in PBS 
flow, fixed in 4% PFA for 15 min at RT in static conditions and then 
permeabilized for 5 min in 0.2% Triton X-100 (Sigma-Aldrich, Missouri, 
USA). For actin fiber organization, cells were incubated in the dark for 
60 min with PhalloidinAtto488 (Sigma Aldrich) 30 µL mL−1 in PBS. 
To monitor cell–cell contact, HUVECs were stained with VE-cadherin 
mouse monoclonal antibody (ThermoFisher Scientific) at 5 µg mL−1 in 
3% BSA for 1 h. Cells were then incubated in the dark with 2 µg mL−1 
of AlexaFluor647 conjugate-Goat anti-Mouse IgG (H+L) Secondary 
Antibody (ThermoFisher Scientific) for 30 min at RT. Depending on the 
experiment, cells were stained before US exposure to assess endothelial 
maturation; immediately after US exposure to evaluate the effect on the 
endothelium and 45 min after US exposure to address endothelium 
integrity recovery under flow conditions. Nuclei were stained with DAPI 
(Thermo Fischer Scientific).
Microbubbles: SonoVue microbubbles (Bracco Research, Geneva, 
Switzerland), filled and stabilized with sulfur hexafluoride (SF6) and 
coated with a phospholipid monolayer shell, were used in this study. The 
bubbles suspension was reconstituted in 5 mL of 0.2% NaCl solution 
(2 × 108–5 × 108 microbubbles mL−1) according to the manufacturer’s 
instructions. The preparation was diluted to a concentration of 
2 × 107–5 × 107 microbubbles mL−1 in culture media (plus 2.5% HEPES 
as buffer solution) to reach the target cell-bubble ratio (1:1).[52,63] 
Then, the bubble solution was injected into the vascular channel with 
the syringe pump. With a size ranging between 2–8 µm and a mean 
diameter of 2.5 µm, microbubbles were small enough to avoid vascular 
channel obstruction.
Ultrasound Excitation: Ultrasound bursts were generated using 
a signal generator, amplified by a 50-dB power gain amplifier and 
monitored with an oscilloscope. The amplified electrical signal was sent 
to an unfocused, single element, 1 MHz-center-frequency transducer 
with a 0.5 in (12.7 mm) diameter that transmits the US signal within 
a custom insonication chamber containing water. The US emitter was 
mounted on a dedicated support with an inclination of 45° at a distance 
of 35 mm from the microfluidic chip, i.e., well into the far-field where 
uncontrolled pressure wave variations were absent. The emitter was 
previously calibrated using a needle hydrophone, see Figure SM6 in the 
Supporting Information showing the details of the piezo calibration. To 
guarantee precise control over the transducer alignment, a dedicated 
housing was present on the insonication chamber cover lid. A sketch of 
the ultrasound chain is shown in Figure 9C.
Acoustical and Optical Setup: The insonication chamber filled with 
deionized water was positioned on a confocal microscope stage for 
optical observation. Phase contrast imaging was performed to monitor 
real-time vessel integrity and microbubble dynamics. The device was 
stably placed at the bottom of the chamber. Culture medium (plus 
2.5% HEPES) was injected into the vascular channel at the flow rate 
appropriate to the specific conditions (0.5 or 25. µL min−1). The system 
was allowed to adapt to the new conditions for 30 min while kept at 37 °C 
by a PID thermal controller (Figure 9C). Cells were monitored with a time-
lapse, acquiring 1 image per second with an exposure time of 300 ms.
Sonovue microbubbles were finally injected at 1, 3, 5, and 25 µL min−1 
rate into the vascular channel and exposed to sine-wave bursts with 
1 MHz central frequency, 500 cycles, 0.1% DC, corresponding to 
500 µs Pulse Duration (PD) and 20 Hz PRF. Two different insonication 
conditions were realized, namely ultrasound emitted for 30 s 
(corresponding to 600 pulses) by the piezo-transducer driven at 80 and 
140 mV, corresponding to a peak negative pressure (PNP) of 0.4 MPa 
(5 W cm−2 intensity level) and 0.72 MPa (17 W cm−2 intensity level), 
respectively. Time-lapse imaging at 10 fps with 10 ms exposure time was 
used to visualize bubble dynamics.
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Figure 9. Vessel-on-a-chip and integrated platform for USMB irradiation. A) Sketch of the geometry showing the tissue compartment (red) surrounded 
by two independent vascular channels (blue). B) Picture of the vessel-on-a-chip showing inlet and outlet tubings. C) Sketch of the ultrasound chain 
showing the dedicated insonication chamber, the microfluidic chip placed at the chamber bottom (enlarged view on the bottom left of the image), the 
thermal control to keep the biological system at 37°, the piezo-actuator generating the US at 1 MHz, and the MB injection syringe.
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Image Analysis: Confocal images of different portions of the 
endothelium were acquired using a 20× magnification objective and 
successively stitched together to reconstruct the whole channel. 
Intercellular gaps were identified by inspection using the ImageJ 
software, creating a rectangular Region of Interest (ROI) enclosing the 
gap at its center. The channel image was then post-processed by using 
the list of ROIs. Image histograms within each ROI were equalized in 
order to increase the contrast and better identify the gap. Binarization 
was then obtained with a threshold method using the same cutoff value 
for all ROIs. The gap area was then quantified counting the black pixels 
of the central connected blob in each binarized image. An example of 
ROIs with the detected gaps is reported in Figure SM7 in the Supporting 
Information.
Statistical Analysis: Statistical analysis was performed by unpaired 
t-tests, 99% confidence interval, using GraphPad Prism software. 
Average values of at least three independent experiments +/− SEM are 
shown. Comparisons between samples were considered to be statistically 
significant if the p-value was *p < 0.05, **p < 0.01, ***p < 0.001.
Supporting Information
Supporting Information is available from the Wiley Online Library or 
from the author.
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